boston.com Business your connection to The Boston Globe

FDA has no reports of drugs from Canada harming US users

WASHINGTON -- Although they've been warning Americans about the dangers of prescription drugs from Canada for nearly a year, US Food and Drug Administration officials can't name a single American who has been injured by drugs bought from licensed Canadian pharmacies.

"We don't have that," said Tom McGinnis, the FDA's director of pharmacy affairs. "I can't think of one thing off the top of my head where somebody died or somebody got put in the hospital because of these medications. I just don't know if there's anything like that."

Neither does Canada.

Health Canada, which regulates Canada's prescription industry, "does not have any information that would indicate that any Americans have become ill or have died as a result of taking prescription medications purchased from Canada," said Jirina Vlk, a spokeswoman for Health Canada.

That doesn't mean there are no such cases, nor does it mean that all drugs from Canada are safe. But the absence of documented harm strongly suggests that medications obtained from licensed Canadian pharmacies are safe and raises questions about whether the FDA may be overstating the risk of buying less expensive Canadian drugs.

FDA Commissioner Mark McClellan, in a recent speech in Canada before a group of drug information specialists, said the agency had found "thousands of examples of unapproved and potentially unsafe medicines" coming into the United States from "many countries, including from Canada."

In another news conference in Ottawa, McClellan was more specific, according to news reports, saying there were "lots of examples of unsafe drugs coming into the United States from Canada."

A recent report by the Congressional Research Service -- the Library of Congress expert that Congress turns to for objective information -- supports the safety of drugs from Canada. It found that medications manufactured and distributed in Canada meet or surpass quality control guidelines set by the FDA.

Concern that the FDA may be misleading consumers has hurt its credibility among some Capitol Hill lawmakers, who say the agency is carrying water for the powerful drug industry.

"There's no question in my mind that the [FDA] is too dependent on the pharmaceutical industry for their attitudes and decision-making," said Republican Representative Dan Burton of Indiana, who chairs a House subcommittee that's studied the issue.

"I had four hearings and I asked [FDA associate commissioner William Hubbard] to give me examples where people have been damaged by Canadian pharmaceuticals and reimportation, and he couldn't even give me one, not one."

In response to Burton, Hubbard cited examples of people who got the wrong drugs from Canadian pharmacies. While that's a danger, US pharmacists make similar errors. Hubbard also told Burton the FDA thinks many people don't report adverse incidents that result from Canadian drugs.

That's because they fear being prosecuted for violating federal laws against foreign drug imports, said Carmen Catizone, executive director of the National Association of Boards of Pharmacy, a Park Ridge, Ill., group that represents state boards appointed by US and Canadian governors.

In testimony before the Senate Commerce Committee, Catizone said injuries from bad drugs might not surface for years and then might not be linked to Canadian drugs.

McGinnis said FDA warnings about bad drugs from Canada were valid and reflected the "buyer beware" caution that's justified when people buy drugs via the Internet.

"A lot of Internet pharmacies that claim to be Canadian aren't even based in Canada," McGinnis said.

US spending on Canadian drugs is expected to hit $1.4 billion this year.

SEARCH GLOBE ARCHIVES
 
Globe Archives Sale Today (free)
Yesterday (free)
Past 30 days
Last 12 months